Can Testosterone Therapy Affect Fertility? What Men Need to Know

Disclaimer: The content provided on this website is for informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. The information presented does not constitute medical recommendations and should not be used to guide clinical decisions. Always seek the advice of a licensed healthcare provider regarding any medical condition or treatment. Do not disregard or delay professional medical care based on information found on this site. Some services may involve compounded medications that have not been reviewed by the FDA for safety or effectiveness; no therapeutic claims are made for these products. Visuals are for illustrative purposes only; individuals shown are not actual patients. Individual results may vary. See full safety information for more details.

A familiar scenario in clinic starts like this.

A man in his late 20s or 30s comes in feeling off.

✓ Energy isn’t what it used to be.

✓ Motivation is inconsistent.

✓ Recovery from workouts takes longer.

✓ Libido has changed.

✓ Focus feels dull.

✓ Sleep isn’t as restorative.

✓ He’s still functioning, but something feels different.

Labs are drawn, and testosterone comes back low.

There’s relief in finally having an explanation.

Then the next sentence shifts the conversation:

“We want kids soon.”

Or, “We’re thinking about trying next year.”

Or sometimes, “We’re not trying yet, but I don’t want to mess anything up.”

That’s where planning matters.

Testosterone therapy can affect fertility. In some men, it can significantly reduce sperm production. That doesn’t automatically mean permanent infertility, but it does mean reproductive goals should be part of the discussion before starting therapy and revisited along the way (Bhasin et al., 2018; AUA & ASRM, 2024).

To understand why this happens, it helps to step back and look at how sperm production is actually controlled.

How the body regulates sperm production

Most people assume testosterone and sperm are the same process. They’re connected, but they’re regulated differently.

Sperm production is controlled by a communication system between the brain and the testicles. Physicians call this the hypothalamic–pituitary–gonadal axis. The name itself isn’t important. The signaling is.

Here’s what happens in simple terms.

The brain sends a signal.

That signal travels to a small gland at the base of the brain called the pituitary.

The pituitary then releases two key hormones into the bloodstream:

  • Luteinizing hormone (LH)

  • Follicle-stimulating hormone (FSH)

LH tells the testicles to produce testosterone.

FSH supports the cells inside the testicles that help develop sperm.

You can think of LH as the “production” signal and FSH as the “support” signal. Both are required for normal sperm development.

Here’s the detail that surprises many men: the testosterone level inside the testicles needs to be much higher than what appears on a routine blood test. That high local concentration of testosterone is essential for sperm production (Crosnoe et al., 2013; McBride et al., 2016).

This means a strong blood testosterone level does not automatically guarantee that sperm production is normal. The internal environment of the testicles matters just as much.

What changes when testosterone is prescribed

When testosterone is introduced from outside the body—whether by injection, gel, cream, or pellet—blood testosterone levels rise.

The brain monitors hormone levels constantly. When it detects that testosterone levels are elevated, it assumes the body is producing enough.

So it reduces its own signaling.

As a result:

  • LH decreases

  • FSH decreases

When LH drops, the testicles reduce their internal testosterone production.

When FSH drops, sperm development can slow.

From the brain’s perspective, this is efficient. If there is already plenty of testosterone circulating, there is no need to keep stimulating production.

But sperm production depends on those signals. When they decline, sperm production can decline as well.

This mechanism is well established. In fact, testosterone has been studied as a potential male contraceptive because it suppresses sperm production in many men (Patel et al., 2018).

The degree of suppression varies, but the biological response is predictable.

Why symptoms can improve while fertility declines

One of the more confusing parts of this process is that men often feel better on testosterone therapy.

Energy improves. Libido increases. Mood stabilizes. Strength returns.

Meanwhile, sperm production may be decreasing quietly in the background.

This happens because blood testosterone and sperm production are regulated differently. Testosterone therapy restores circulating hormone levels. At the same time, it suppresses the internal signals that drive sperm production.

It is entirely possible to feel physically better while sperm counts are falling.

That’s why fertility planning cannot rely on symptoms alone.

How much can sperm count decline?

The range is broad.

Some men experience only a modest reduction in sperm count. Others develop severe oligospermia (very low sperm count). Some temporarily produce no detectable sperm in their semen, a condition known as azoospermia.

Research shows that suppression can occur within months of starting exogenous testosterone in many individuals (Patel et al., 2018). Clinical reviews consistently identify testosterone therapy as a reversible cause of secondary infertility (Crosnoe et al., 2013).

There is no reliable blood test that predicts who will experience significant suppression. Testosterone levels, LH levels, and FSH levels offer clues, but they do not directly measure sperm production.

The only way to assess sperm production directly is through semen analysis.

Does this mean testosterone causes permanent infertility?

In most cases, no.

For many men, sperm production resumes after testosterone therapy is discontinued. However, recovery timelines vary.

Published data suggest that spermatogenesis often returns over several months, and sometimes up to a year (McBride et al., 2016). Age and duration of prior testosterone use appear to influence how long recovery takes (Kohn et al., 2017).

A younger man who used testosterone for a short period may recover more quickly than someone older who used it for years. But there is no fixed timeline that applies to everyone.

This uncertainty is why early planning matters.

Why fertility goals should be discussed before starting therapy

Professional medical organizations address this clearly.

The Endocrine Society advises against initiating testosterone therapy in men actively planning fertility in the near term (Bhasin et al., 2018).

The American Urological Association and the American Society for Reproductive Medicine recommend that exogenous testosterone not be prescribed to men interested in current or future fertility (AUA & ASRM, 2024).

These recommendations are not meant to dismiss symptoms. They exist to ensure treatment decisions align with long-term priorities.

A thoughtful evaluation before starting therapy may include:

  • Clarifying your family planning timeline

  • Reviewing baseline LH and FSH levels

  • Considering semen analysis

  • Discussing prior testosterone or anabolic steroid exposure

  • Establishing a monitoring plan

These steps reduce the likelihood of unexpected delays when pregnancy becomes a priority.

For men who are unsure about future family plans, that uncertainty itself should be part of the discussion.

Medications that stimulate natural testosterone production

In certain clinical contexts, some providers consider therapies that stimulate the body’s own testosterone production rather than replacing it with external testosterone.

Selective estrogen receptor modulators (SERMs), such as clomiphene citrate, work by increasing the brain’s release of LH and FSH. Instead of shutting down the signaling pathway, they encourage it.

Studies have evaluated clomiphene citrate in men with hypogonadism (Huijben et al., 2022). Enclomiphene citrate has demonstrated increases in testosterone levels while maintaining LH and FSH stimulation in clinical trials (Wiehle et al., 2014; Kim et al., 2016). In those research settings, sperm counts were maintained.

These medications are not appropriate for every patient. They require physician supervision and individualized evaluation. They do not guarantee fertility preservation. They may be considered in certain situations where maintaining fertility is a priority.

Treatment decisions depend on lab findings, medical history, symptom severity, and overall goals.

If you are already on testosterone and want children

If fertility becomes a goal while you are on testosterone therapy, the next step is straightforward: discuss it with your provider.

The earlier that conversation happens, the more flexibility there tends to be.

Evaluation may involve:

  • Updated hormone labs

  • Semen analysis

  • Referral to a reproductive urologist when indicated

Specialist-directed approaches have been used to help restore spermatogenesis after testosterone exposure, though recovery timelines remain variable (Kohn et al., 2017; McBride et al., 2016).

In many cases, fertility returns. In some cases, additional medical support is required. The key is not delaying the conversation.

Practical considerations for men in their 20s and 30s

Younger men often assume fertility is something they can address later.

But testosterone therapy decisions made in your 20s or 30s can influence reproductive timelines.

Questions worth asking include:

  • Are you actively trying to conceive?

  • Do you plan to try within the next year?

  • Do you want children eventually, even if you don’t have a timeline?

  • Have you had a baseline semen analysis?

Answering those questions honestly allows for better alignment between symptom management and long-term goals.

The bigger picture

Low testosterone symptoms are real. Fatigue, reduced motivation, changes in body composition, and libido shifts can meaningfully affect quality of life.

Fertility goals are equally real.

Testosterone therapy can reduce sperm production because it suppresses the brain signals that drive testicular function.

Many men recover fertility after discontinuing therapy, but recovery timing is not uniform.

If having children now or in the future is important to you, that goal should shape the treatment plan from the beginning.

Addressing symptoms and protecting fertility are not mutually exclusive. They simply require thoughtful planning.

 

Book a FREE Care Call Today
to explore how we can help you feel your best.

Active Patient? Schedule your follow-up today and reconnect with your Superior provider for personalized guidance.


Disclaimer

The content provided on this website is for informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. The information presented does not constitute medical recommendations and should not be used to guide clinical decisions. Always seek the advice of a licensed healthcare provider regarding any medical condition or treatment. Do not disregard or delay professional medical care based on information found on this site. Some services may involve compounded medications that have not been reviewed by the FDA for safety or effectiveness; no therapeutic claims are made for these products. Visuals are for illustrative purposes only; individuals shown are not actual patients. Individual results may vary.

References

American Urological Association, & American Society for Reproductive Medicine. (2024). Diagnosis and treatment of infertility in men: AUA/ASRM guideline (2020; amended 2024).

Bhasin, S., et al. (2018). Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism, 103(5), 1715–1744.

Crosnoe, L. E., et al. (2013). Exogenous testosterone: A preventable cause of male infertility. Translational Andrology and Urology, 2(2), 106–113.

Huijben, M., et al. (2022). Clomiphene citrate for men with hypogonadism: A systematic review and meta-analysis. Andrology, 10(4), 787–801.

Kim, E. D., et al. (2016). Oral enclomiphene citrate raises testosterone and preserves sperm counts in obese hypogonadal men. BJU International, 117(4), 677–685.

Kohn, T. P., et al. (2017). Age and duration of testosterone therapy predict time to return of sperm count after therapy. Fertility and Sterility.

McBride, J. A., et al. (2016). Recovery of spermatogenesis following testosterone replacement therapy. Asian Journal of Andrology, 18(3), 373–380.

Patel, A. S., et al. (2018). Testosterone is a contraceptive and should not be used in men who desire fertility. World Journal of Men’s Health, 37(1), 45–54.

Alicia Harrison, APRN, FNP-C

Alicia is a board-certified Family Nurse Practitioner with a passion for empowering patients to lead healthier lives. She takes a holistic approach to healthcare, focusing on hormone balance, mental wellness, and sustainable lifestyle changes. Alicia believes that informed patients make the best health choices and is dedicated to providing personalized care that helps each patient reach their full potential.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

Ready to take the first step?

Book your free CARE Call to explore how you’re feeling and see if our therapy options are the right fit—no pressure, no obligations.

https://www.superiorhealthwellness.com/book-free-call
Next
Next

Is TRT Safe for Your Heart? What the Research Shows